CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME
Apr 24 17:34
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME
Apr 23 17:52
CSPC PHARMA: INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE THREE MONTHS ENDED 31 MARCH 2024
Apr 22 21:32
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 22 18:17
CSPC PHARMA: GRANT OF SHARE AWARDS PURSUANT TO THE SHARE AWARD SCHEME OF THE COMPANY
Apr 22 17:06
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 19 17:51
CSPC PHARMA: CONTINUING CONNECTED TRANSACTIONS IN RELATION TO MASTER SALES AGREEMENT
Apr 19 16:53
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 18 17:45
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 17 18:22
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 16 17:59
CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS
Apr 15 17:28
CSPC PHARMA: EXERCISE OF SHARE OPTIONS UNDER THE SHARE OPTION SCHEME
Apr 15 17:21
CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024
Apr 2 17:38
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - SEMAGLUTIDE INJECTION FOR OVERWEIGHT/OBESITY INDICATION OBTAINS CLINICAL TRIAL APPROVAL
Mar 25 17:07
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - DAPAGLIFLOZIN TABLETS OBTAINS DRUG REGISTRATION APPROVAL
Mar 22 16:31
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE SYS6023 OBTAINS CLINICAL TRIAL APPROVAL
Mar 20 17:25
CSPC PHARMA: CASH DIVIDEND ANNOUNCEMENT FOR EQUITY ISSUER
Mar 20 17:22
CSPC PHARMA: ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Mar 20 12:06
CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE MAT2A INHIBITOR (SYH2039)OBTAINS CLINICAL TRIAL APPROVAL
Mar 18 18:08
CSPC PHARMA: INSIDE INFORMATION - PRINCIPAL FINANCIAL INFORMATION OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2023
Mar 14 19:42
No Data
No Data